创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Strengthen Capacity for Independent Research and Development of New Drug to Address Future Infectious Disease Pandemics
ZHANG Wenhong, WANG Yue
2023, 47(7): 481-483. DOI: 10.20053/j.issn1001-5094.2023.07.001
Abstract PDF
XIANNUOXIN®: China’s First Anti-SARS-CoV-2 Drug Targeting 3C-like Protease
LU Lei, WU Qi, WANG Feng
2023, 47(7): 484-488. DOI: 10.20053/j.issn1001-5094.2023.07.002
Abstract PDF
Clinical Research and Development of Deuremidevir Hydrobromide Tablets for the Treatment of COVID-19
MA Juan, PAN Yali
2023, 47(7): 489-493. DOI: 10.20053/j.issn1001-5094.2023.07.003
Abstract PDF
Research and Development Practice and Strategy of 3C-like Protease Inhibitor Bofutrelvir
XIE Dong, HU Min, YAO Cheng
2023, 47(7): 494-498. DOI: 10.20053/j.issn1001-5094.2023.07.004
Abstract PDF
Androgen Receptor Antagonist Pruxelutamide: a Novel Anti-COVID-19 Drug with Dual Mechanisms of Action
TONG Youzhi, MA Liandong
2023, 47(7): 499-503. DOI: 10.20053/j.issn1001-5094.2023.07.005
Abstract PDF
Research Progress in the Application of Nanoformulations in Transdermal Drug Delivery Systems
LI Xuanhuan, LYU Huixia, ZHU Lyufeng
2023, 47(7): 504-518. DOI: 10.20053/j.issn1001-5094.2023.07.006
Abstract PDF
Advances in Research on Drugs for Treatment of COVID-19
ZHU Junliang, DAI Quan, ZHU Ren, LONG Sihui, YU Wenying
2023, 47(7): 519-531. DOI: 10.20053/j.issn1001-5094.2023.07.007
Abstract PDF
Research Progress of Changes in Expression and Function of Organic Anion Transporters and Their Mechanisms in Disease States
SUN Xueying, LIU Li
2023, 47(7): 532-541. DOI: 10.20053/j.issn1001-5094.2023.07.008
Abstract PDF
Advances in Research on the Role of Immune Cells in the Process of Atherosclerosis
LI Jingyu, LI Qi, CHEN Chang
2023, 47(7): 542-550. DOI: 10.20053/j.issn1001-5094.2023.07.009
Abstract PDF
Study on Drug Royalty Investment Mode and Its Feasibility Analysis in China
YANG Shujun, WANG Qingqing, ZHOU Bin
2023, 47(7): 551-560. DOI: 10.20053/j.issn1001-5094.2023.07.010
Abstract PDF